Ismail MD, et al. - Researchers investigated the efficacy of coronary angioplasty to treat ST-elevation myocardial infarction (STEMI) patients with renal impairment, by analyzing the Malaysian National Cardiovascular Disease Database-Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014. They found that the combination of STEMI and chronic kidney disease (CKD) is deadly. Malaysian STEMI CKD patients tended to be younger than their Caucasian counterparts, with an enormously high prevalence of diabetes mellitus. This group must be treated more efficiently because these patients developed immediate or short-term peri-procedural adverse events, which primarily accounted for the poor outcome in these subjects.